In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

scientific article published on January 2002

In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MDS.10078
P698PubMed publication ID11835448

P50authorJau-Shyong HongQ63384716
P2093author name stringJack W Lipton
Dave A Gayle
Paul M Carvey
Chong Wai Tong
Shang Yong Ma
ZaoDung Ling
P2860cites workDifferential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birthQ78168590
Aetiology of Parkinson's diseaseQ28261357
Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's diseaseQ28324372
Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neuronsQ28511306
Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesisQ33631298
Current evaluation and management of vulvovaginitisQ33660444
Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease developmentQ33669393
Redox regulation of TNF signalingQ33803280
Parkinson's disease: pathophysiologyQ36495393
Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonismQ37686045
Parkinson's disease in twins: a follow-up studyQ38448503
CD14 and other recognition molecules for lipopolysaccharide: a reviewQ40402783
Role of prostaglandins in mediating alterations in glucose metabolism during acute endotoxemia in the rat.Q40686408
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transductionQ40962119
Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic culturesQ41033477
Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokinesQ41059727
Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat.Q41079201
6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factorQ41170164
Does prepregnancy bacterial vaginosis increase a mother's risk of having a preterm infant with cerebral palsy?Q41684601
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog proteinQ42479348
Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neuronsQ42504503
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron agingQ43480259
Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's diseaseQ43564955
Administration of interleukin-1 at birth affects dopaminergic neurons in adult miceQ47966803
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigraQ48189864
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patientsQ48191627
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twinsQ48216713
The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine positionQ48414876
Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitroQ48584015
Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's diseaseQ48594533
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector countsQ48616749
The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigraQ48797592
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing.Q52137725
Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women.Q52245653
Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogenyQ52293274
Cytokine secretion by human fetal membranes, decidua and placenta at termQ61415524
Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartmentsQ61845615
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.Q67403760
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineQ70951248
Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrationsQ71181808
Glia-dependent neurotoxicity and neuroprotection in mesencephalic culturesQ71377883
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levelsQ72417927
Expression of inflammatory cytokines (interleukin-1 beta and interleukin-6) in amniochorionic membranesQ72547092
Striatal trophic activity is reduced in the aged rat brainQ73455130
Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamineQ73881020
Chorioamnionitis reduces placental endocrine functions: the role of bacterial lipopolysaccharide and superoxide anionQ74261164
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectendotoxinsQ319997
P304page(s)116-124
P577publication date2002-01-01
P1433published inMovement DisordersQ1486418
P1476titleIn utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
P478volume17

Reverse relations

cites work (P2860)
Q36493835Alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain
Q46684395Alpha-phenyl-n-tert-butyl-nitrone ameliorates hippocampal injury and improves learning and memory in juvenile rats following neonatal exposure to lipopolysaccharide
Q35792836Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide
Q35046915An inflammatory review of Parkinson's disease.
Q33390827Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes
Q36924624Animal models of Parkinson's disease progression
Q35813131Aspects of innate immunity and Parkinson's disease
Q30391351Astaxanthin ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in adult offspring.
Q28387937CNS infections, sepsis and risk of Parkinson's disease
Q37213687Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein
Q42726407Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system
Q34886336Cytokines and perinatal brain damage
Q34748994Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes
Q36952358Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner.
Q35639110Developmental neuropathology of environmental agents.
Q28383196Developmental neurotoxicity: some old and new issues
Q35611320Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity
Q27498993Does neuroinflammation fan the flame in neurodegenerative diseases?
Q37251953Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.
Q34510971Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.
Q48435759Early life environment: does it have implications for predisposition to disease?
Q35990909Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study
Q42243282Effect of prenatal infection of mice with bacterial endotoxin on the migration of neurons producing gonadotropin-releasing hormone
Q37338674Effects of Regular Treadmill Exercise on a DNA Oxidative-Damage Marker and Total Antioxidant Capacity in Rat Hippocampal Tissue.
Q36133711Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat.
Q34516073Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.
Q37387824Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
Q36721776Estrogen action in neuroprotection and brain inflammation.
Q42112840Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats
Q28388674Gene-environment interactions: key to unraveling the mystery of Parkinson's disease
Q48467010Hypoactivity of the central dopaminergic system and autistic-like behavior induced by a single early prenatal exposure to lipopolysaccharide
Q41262976Immune responses in Parkinson's disease: interplay between central and peripheral immune systems
Q40263168Infections as a risk factor for Parkinson's disease: a case-control study.
Q36052641Inflammation as a causative factor in the aetiology of Parkinson's disease
Q38040993Innate inflammation in Parkinson's disease
Q36512406Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures
Q38103856Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Q37217248Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
Q33508801Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration
Q80678600MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity
Q48062607Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson's Disease Model.
Q35069372Maternal infection and white matter toxicity
Q33548162Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease
Q29547835Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Q37794379Microglial activation and chronic neurodegeneration
Q46567817Microglial cells and Parkinson's disease
Q34037199Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
Q36616362Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease
Q36913314Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life
Q35255816Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
Q37182878Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
Q33663970Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention
Q42908536Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease
Q36919403Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention
Q35876266Oxidative stress and microglial cells in Parkinson's disease
Q37097440PRENATAL INFECTION, MATERNAL IMMUNE ACTIVATION, AND RISK FOR SCHIZOPHRENIA.
Q37679695Paraquat and Parkinson's disease
Q24815148Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation
Q42651923Parkinson's disease and systemic inflammation
Q28084395Parkinson's disease as a result of aging
Q39327711Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
Q46736932Pathological dynamics of activated microglia following medial forebrain bundle transection
Q64934156Peli1 controls the survival of dopaminergic neurons through modulating microglia-mediated neuroinflammation.
Q37607849Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.
Q34587666Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice
Q38021432Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders
Q36367080Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice
Q37116911Prevotella bivia as a source of lipopolysaccharide in the vagina
Q36485934Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis
Q37336951Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response
Q28386323Role of early life exposure and environment on neurodegeneration: implications on brain disorders
Q44323441Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.
Q24614960Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Q48453030Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats
Q30466613The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease
Q39737653The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.
Q34557246The endotoxin-induced neuroinflammation model of Parkinson's disease.
Q35206992The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
Q37076726The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Q48794767The morphogenetic effect of bacterial endotoxin lipopolysaccharide on the functioning of the reproductive system in rats
Q24815642The role of early life environmental risk factors in Parkinson disease: what is the evidence?
Q45128097The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats
Q36331560The role of inflammation in perinatal brain injury
Q45076613Transient parkinsonism: induced by progesterone or pregnancy?
Q46132067Updates on immunity and inflammation in Parkinson disease pathology
Q88917772Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation

Search more.